Clinical Trials Browser

Phase 1/2 × OTHER × N,N-dicyclohexyl-isoborneol-10-sulfonamide × Clear all

NCT03512405 2025-05-30

Pembrolizumab and Blinatumomab in Treating Participants With Recurrent or Refractory Acute Lymphoblastic Leukemia

Phase 1/2 Active not recruiting

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma